Polymorphonuclear (PMN) elastase levels in depressive disorders

Biological Psychiatry

Volumn 39, Issue 5, 1996, Pages 357-363

  Deǧer, Orhan ^a   Bekaroǧlu, Mehmet ^a   Örem, Asim ^a   Örem, Serpil ^a   Uluutku, Nafiz ^a   Soylu, Cengiz ^a  

^a KARADENIZ TECHNICAL UNIVERSITY   (Turkey)

Author keywords

Biological markers; Depression; Immune system; PMN elastase

Indexed keywords

ELASTASE;

ADULT; ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DEPRESSION; DISEASE SEVERITY; DYSTHYMIA; FEMALE; HUMAN; IMMUNE RESPONSE; INFLAMMATION; LEUKOCYTE COUNT; MAJOR CLINICAL STUDY; MALE; POLYMORPHONUCLEAR CELL; PRIORITY JOURNAL;

EID: 0343526166     PISSN: 00063223     EISSN: None     Source Type: Journal    
DOI: 10.1016/0006-3223(95)00176-X     Document Type: Article

References (35)

1. American Psychiatric Association (1987): Diagnostic and Statistical Manual of Mental Disorders, 3rd ed rev. Washington DC: American Psychiatric Association.
2. Baici A, Knöpfel M, Fehr J, Boni A (1980): Cleavage of human IgM with lysosomal elastase. Immunol Lett 2:47-50.
3. Bieth JG (1989): Human neutrophil elastase. In Robert L, Hornebeck W (eds), Elastin and Elastases, vol 2. Boca Raton, FL: CRC Press, pp 23-31.
4. Bunney WE, Gerland-Bunney B, Palel SB (1986): Biological markers in depression. Psychopathology 19(suppl):72-78.
5. Calabrese JR, Skwerer RG, Barna B, et al (1986): Depression, immunocompetence, and prostaglandins of the E series. Psychiatry Res 17:41-47.
6. Dawson-Saunders B, Trapp RG (1994): Basic & Clinical Biostatistics. London: Prentice Hall International.
7. Deǧer O, Örem A, Akyol N, Bahadir S, Yildirmiş, S (1995): PMN elastase levels in patients with Behçet's disease. Clin Chim Acta (in press).
8. Fink PC, de Boutemard CS, Haeckel R (1989): Measurement of leukocyte elastase alpha-1-proteinase-inhibitor complex using a homogenous and heterogeneous enzyme-immunoassay. J Clin Chem Clin Biochem 27:868-871.
9. Gerson ES, Berettini WH, Goldin CR (1989): Mood disorders: Genetic aspects. In Kaplan HC, Sadock BJ (eds), Comprehensive Textbook of Psychiatry. Baltimore: Williams and Wilkins, pp 879-887.
10. Goodman J (1987): Immunoglobulins, structure and function. In Stites D, Stobo J, Wells J (eds), Basic and Clinical Immunology. Norwalk & New York: Lange Medical Publ., pp 27-36.
11. Gross V, Schölmerich J, Leser H.-G, et al (1990): Granulocyte elastase in assessment of severity of acute pancreatitis. Dig Dis Sci 35:97-105.
12. Hamilton M (1960): A rating scale for depression. J Neurol Neurosurg Psychiatry 23:56-61.
13. Hastka J (1988): The importance of granulocyte elastase in haematological diagnosis. Blut 57:69-75.
14. Heinrich PC, Castell JV, Andus T (1990): Interleukin-6 and the acute phase response. Biochem J 265:621-636.
15. İmamogľu M, Çiftçi A, Deǧer O, Gedik Y, Yücetürk AV (1993): Plasma polymorphonuclear elastase-alpha 1-proteinase levels of patients with acute purulent otitis media and secretory otitis media. Proceedings of the XV World Congress of Otorhinolaryngology Head and Neck Surgery, vol I. Istanbul, Turkey, pp 157-167.
16. Joyce PR, Hawes CR, Mulder RT, et al (1992): Elevated levels of acute phase plasma proteins in major depression. Biol Psychiatry 32:1035-1041.
17. Kuramitsu K, Yoshida A (1990): Plasma and synovial fluid levels of granulocytal elastase-alpha-1-protease inhibitor complex in patients with rheumatoid arthritis. Rheumatol Int 10:51-56.
18. Lang H, Gunzer G, Hennrich N, et al (1985): Granulocyte enzymes and inflammatory diseases. In Froeschle MC, Goetz WA (eds), Elastase: A New Marker for Inflammatory Diseases. Darmstadt Germany, GIT Verlag, pp 1-14.
19. Link H (1979): Some aspects of immune reactions of the brain. In Rose FC (ed), Clinical Neuroimmunology. Oxford England, Blackwell Scientific Publ, pp 12-28.
20. Maes M, Bosmans E, Suy E, et al (1991): Depression-related disturbances in mitogen-induced lymphocyte responses and interleukin-1β and soluble interleukin-2 receptor protein. Acta Psychiatr Scand 84:379-386.
21. Maes M, Lambrechts J, Bosmans E, et al (1992a): Evidence for a systemic immune activation during depression: results of leukocyte enumeration by flow cytometry in conjunction with monoclonal antibody staining. Psychol Med 22:45-53.
22. Maes M, Van der Planken M, Stevens W, et al (1992b): Leukocytosis, monocytosis and neutrophilia: Hallmarks of severe depression. J Psychiatr Res 26:125-134.
23. Maes M, Stevens W, DeClerck L, et al (1992c): İmmune disorders in depression: Higher T helper/T suppressor-cytotoxic cell ratio. Acta Psychiatr Scand 86:423-431.
24. Maes M, Stevens WJ, DeClerck LS, et al (1992d): A significantly increased number and percentage of B cell in depressed subjects: results of flow cytometric measurements. J Affective Disord 24:127-134.
25. Maes M, Scharpe S, Meltzer HY, et al (1993a): Relationships between interleukin-6 activity, acute phase proteins, and function of the hypothalamic-pituitary-adrenal axis in severe depression. Psychiatry Res 49:11-27.
26. Maes M, Steven W, DeClerck LS, et al (1993b): A significantly increased expression of T cell activation markers in depression: Additional evidence for an inflammatory process during that illness. Prog Psycopharmacol Biol Psychiatry 17:214-225.
27. Maes M, Meltzer HY, Jacobs J, et al (1993c): Autoimmunity in depression: increased antiphospholipid autoantibody titers. Acta Psychiatr Scand 87:160-166.
28. Maes M, Scharpe S, Meltzer HY, Cosyns P (1993d): Relationships between increased haptoglobulin plasma levels and activation of cell-mediated immunity in depression. Biol Psychiatry 34:690-701.
29. Maes M, Meltzer HY, Scharpe S, et al (1993e): Psychomotor retardation, anorexia, weight loss, sleep disturbances, and loss of energy: Psychopathological correlates of hyperhaptoglobulinemia during major depression. Psychiatry Res 47:229-241.
30. Miller AH, Norin AJ (1989): Neural immune interactions. In Miller AH (ed), Depressive Disorders and Immunity. Washington DC: American Psychiatric Press, pp 25-49.
31. Nelson DA, Davey F (1991): Hematopoiesis. In Henry JB (ed), Clinical Diagnosis & Management by Laboratory Methods, 18th ed. Philadelphia, PA: WB Saunders Co. pp 604-626.
32. Neumann S, Lang H (1985): Recent results of the PMN elastase/ alpha-1-proteinase inhibitor complex assay. In Froeschle MC, Goetz WA (eds), Elastase: A New Marker for Inflammatory Diseases. Darmstad, Germany: GIT Verlag, pp 39-44.
33. Prowse KR, Baumann H (1989): Interleukin-1 and interleukin-6 stimulate acute phase protein production in primary mouse hepatocytes. J Leukocyte Biology 45:55-61.
34. Song C, Leonard BE (1994): An acute phase protein response in the olfactory bulbectomised rat: effect of sertraline treatment. Med Sci Res 22:313-314.
35. Werner M (1985): Validation of inflammation indicators: utility of elastase assay. In Froeschle MC, Goetz WA (eds), Elastase: A New Marker for Inflammatory Disease. Darmstadt, Germany: GIT Verlag, pp 15-26.